Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States.
about
Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic reviewHyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes.Quality of Care for Patients With Chronic Kidney Disease in the Primary Care Setting: A Retrospective Cohort Study From Ontario, CanadaUse of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic.The growth of acute kidney injury: a rising tide or just closer attention to detail?NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011.Chronic pain and analgesic use in CKD: implications for patient safety.Analgesic use in a Norwegian general population: change over time and high-risk use--The Tromsø Study.CKD as a Model for Improving Chronic Disease Care through Electronic Health Records.Causes of end stage renal failure among haemodialysis patients in Khartoum State/Sudan.High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort studyAn observational study of the quality of care for chronic kidney disease: a Buffalo and Albany, New York metropolitan area study.Healthy behaviors, risk factor control and awareness of chronic kidney diseaseUpper gastrointestinal bleeding as a risk factor for dialysis and all-cause mortality: a cohort study of chronic kidney disease patients in Taiwan.Estimated GFR reporting is associated with decreased nonsteroidal anti-inflammatory drug prescribing and increased renal functionPeptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications.Pain in chronic kidney disease: a scoping review.Estimating One-Year Risk of Incident Chronic Kidney Disease: Retrospective Development and Validation Study Using Electronic Medical Record Data From the State of Maine.Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease.Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector.Inappropriate use of nonsteroidal anti-inflammatory drugs and other drugs in chronic kidney disease patients without renal replacement therapy.Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan.In this issue: from apprehension to action.Pain, analgesics, and safety in patients with CKD.Status of non-steroidal anti-inflammatory drugs use and its association with chronic kidney disease: a cross-sectional survey in China.A new low nephron-CKD model with hypertension, progressive decline of renal function and enhanced inflammation in C57BL/6 mice.Association of herbal and dietary supplements with progression and complications of chronic kidney disease: a prospective cohort study.Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study.Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD.Factors influencing use of analgesics among construction workers in the Ga-Eastmunicipality of the Greater Accra region, Ghana.The use of START/STOPP criteria for elderly patients in primary care.
P2860
Q27000437-8ABE5A8D-1A31-45B9-AEE8-DB094E451B7FQ33701269-DE35BBCC-F239-4EC4-83DA-29C7DA18D8D2Q33772228-E0F727F4-9637-4242-B4E0-0E25BEE44701Q33801854-BAB60843-E806-4771-B0D9-3BC0C73B9527Q34439098-0CB96466-3C53-404D-87B2-64BC735C5798Q34754712-E50E12D3-9417-4701-AAE4-65C6AFFEDB87Q35144435-0A86CF3F-1B11-4A04-B273-992ABD2DCDB6Q35654986-00009E39-620D-4146-9CEF-B1D31BDFB570Q35674779-59966106-8440-424D-92C2-5D19C5B82B0DQ35792346-E3EB3350-4F1A-405B-983E-9C59AA5387A9Q36202852-5628468D-A934-4A5B-98E2-E74A31108003Q36346721-812BCDD9-82E8-447D-B505-CBCDB504DD7FQ36829432-528125F3-5A95-4317-88E9-050166959028Q36883788-BDEDC2B5-B8BF-4649-9B48-3BB4498243A5Q36968784-E36F814A-924F-4C9E-87E5-078A833E29ABQ37549220-297A5665-77A3-4EB7-BA18-74C7149DF4AEQ38187185-702FB39A-E2D2-47C6-B224-0350C950633DQ38659530-E3A57E6D-F5AB-483C-A483-BF93B86BDDEAQ39147420-B5A4F75F-15B3-4C79-A9FC-4CC74163E278Q39344806-A01A3C34-AD07-481A-8FD5-43CCFA46B80AQ39841690-62199CED-0CA0-434E-87B0-0F5E0C37BAEFQ40114676-534E05F6-FB9C-4293-A273-96AF680E56FFQ40590475-A7E5E857-54F9-4EEB-9E2A-2A59AAE2873AQ42929326-7AF240CF-3559-4602-BFAB-C47BF0833BD2Q43174153-6358E70E-7898-4C6C-B4CF-32ABE6BDD066Q43449223-3A0E701C-2342-44B4-87C2-1DA6318357C8Q50141004-9B0E83C0-B392-4ACE-BA59-33412190A8E3Q50909304-E65D7250-96A8-4ED4-AF23-3388DA4F1F01Q51131123-D264ADBF-E3C3-40F7-8653-CBB8FA4F9736Q51349873-398892FF-4C13-4C65-869E-D0EFE989959EQ55117478-5F7B43E7-F314-49ED-B067-D5FD16D21065Q55712157-B24355F2-DC50-4278-AEC4-61411385396B
P2860
Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Nonsteroidal anti-inflammatory ...... disease in the United States.
@ast
Nonsteroidal anti-inflammatory ...... disease in the United States.
@en
type
label
Nonsteroidal anti-inflammatory ...... disease in the United States.
@ast
Nonsteroidal anti-inflammatory ...... disease in the United States.
@en
prefLabel
Nonsteroidal anti-inflammatory ...... disease in the United States.
@ast
Nonsteroidal anti-inflammatory ...... disease in the United States.
@en
P2093
P2860
P356
P1476
Nonsteroidal anti-inflammatory ...... disease in the United States.
@en
P2093
Bruce Robinson
CDC CKD Surveillance Team
Chi-Yuan Hsu
Elizabeth Hedgeman
Laura Plantinga
Mark Eberhardt
Nilka Ríos Burrows
Rajiv Saran
Urmimala Sarkar
P2860
P304
P356
10.1370/AFM.1302
P407
P577
2011-09-01T00:00:00Z